MKI67 and breast carcinoma: These data also inform the clinical use of 18F-ISO-1 in breast cancer, in which 18F-ISO-1 correlated with Ki-67, providing independent clinical trial data supporting the association of a component of the trimeric complex with breast cancer proliferation (39).